MicroRNA-145: a promising biomarker for hepatocellular carcinoma (HCC)

Xianchun Duan; Jianpeng Hu; Yongzhong Wang; Jiarong Gao; Daiyin Peng; Lunzhu Xia

doi:10.1016/j.gene.2014.03.018

MicroRNA-145: a promising biomarker for hepatocellular carcinoma (HCC)

Gene. 2014 May 10;541(1):67-8. doi: 10.1016/j.gene.2014.03.018. Epub 2014 Mar 11.

Authors

Xianchun Duan¹, Jianpeng Hu², Yongzhong Wang¹, Jiarong Gao¹, Daiyin Peng², Lunzhu Xia³

Affiliations

¹ First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, Anhui 230031, China.
² Anhui University of Chinese Medicine, China.
³ First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, Anhui 230031, China. Electronic address: dxcflying2014@163.com.

PMID: 24630966
DOI: 10.1016/j.gene.2014.03.018

Abstract

It has been demonstrated that microRNA-145 (miR-145) is downregulated in patients with hepatocellular carcinoma (HCC) compared with healthy controls. The mechanisms for miR-145 in HCC will become potential in future researches.

Keywords: Hepatocellular carcinoma; miR-145.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Carcinoma, Hepatocellular / genetics*
Cholangiocarcinoma / genetics*
Female
Gene Expression Regulation, Neoplastic*
Humans
Liver Neoplasms / genetics*
Male
MicroRNAs / genetics*

Substances

MicroRNAs